menu
    • menu

    Company profile for Allos Pharma

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    We are a global team dedicated to improve the lives of patients with Fragile X Syndrome and Autism Spectrum Disorder. Our work spans three decades of research in neuroscience and intellectual disabilities. The “mGluR theory of fragile X” proposed by MIT Professor Mark Bear and collaborators in 2004 is widely considered to be a key conceptual breakthrough, and laid the foundation for development of disease-modifying therapi...
    We are a global team dedicated to improve the lives of patients with Fragile X Syndrome and Autism Spectrum Disorder. Our work spans three decades of research in neuroscience and intellectual disabilities. The “mGluR theory of fragile X” proposed by MIT Professor Mark Bear and collaborators in 2004 is widely considered to be a key conceptual breakthrough, and laid the foundation for development of disease-modifying therapies for treatment of Fragile X Syndrome and Autism Spectrum Disorder. Allos Pharma is committed to develop and market the first approved therapy in Fragile X Syndrome.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Allos PharmaUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    11080 Circlepoint Rd, Ste 200, Westminster, Colorado, 80020
    Telephone
    Telephone
    (303) 426-6262
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.allospharma.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Allos Pharma Secures Rights to Arbaclofen After ASD Trial Win
    Allos Pharma Secures Rights to Arbaclofen After ASD Trial Win

    21 Aug 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/allos-pharma-acquires-global-rights-to-arbaclofen-reports-positive-asd-trial-results-and-grant-award-302535689.html

    PR NEWSWIRE
    21 Aug 2025
    Share Share
    Sudo Biosciences Doses First Participants in TYK2 Inhibitor Trial
    Sudo Biosciences Doses First Participants in TYK2 Inhibitor Trial

    02 Dec 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241202300740/en

    BUSINESSWIRE
    02 Dec 2024
    Share Share
    Damona Pharmaceuticals Receives FDA Clearance for DPX-101 IND
    Damona Pharmaceuticals Receives FDA Clearance for DPX-101 IND

    04 Nov 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/damona-pharmaceuticals-announces-fda-clearance-of-ind-application-for-a-phase-1-clinical-trial-of-dpx-101-a-positive-allosteric-modulator-targeting-the-5-gaba-a-receptor-subtype-selectively-with-broad-therapeutic-potential-to-t-302294895.html

    PR NEWSWIRE
    04 Nov 2024
    Share Share
    Gain Therapeutics Presents Data on DDR2 Inhibitors at EORTC
    Gain Therapeutics Presents Data on DDR2 Inhibitors at EORTC

    23 Oct 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/10/23/2967725/0/en/Gain-Therapeutics-Presents-Data-at-36%E1%B5%97%CA%B0-EORTC-NCI-AACR-Symposium-on-Molecular-Targets-and-Cancer-Therapeutics-Demonstrating-Identification-of-Allosteric-Inhibitors-Targeting-DDR2.html

    GLOBENEWSWIRE
    23 Oct 2024
    Share Share
    Atavistik Bio Presents Preclinical Data on ATV-1601 at EORTC
    Atavistik Bio Presents Preclinical Data on ATV-1601 at EORTC

    23 Oct 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/10/23/2967581/0/en/Atavistik-Bio-Presents-Preclinical-Data-on-Precision-Oncology-Development-Candidate-ATV-1601-a-Selective-Allosteric-AKT1-E17K-Small-Molecule-Inhibitor-at-EORTC-NCI-AACR-Symposium.html

    GLOBENEWSWIRE
    23 Oct 2024
    Share Share
    Allos Pharma Inc. Expands Intellectual Property Rights for Arbaclofen
    Allos Pharma Inc. Expands Intellectual Property Rights for Arbaclofen

    18 Sep 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/allos-pharma-inc-expands-intellectual-property-rights-for-arbaclofen-301930753.html

    PR NEWSWIRE
    18 Sep 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search